Adrenergic-pathway gene variants influence beta-blocker-related outcomes after acute coronary syndrome in a race-specific manner.
Journal of the American College of Cardiology 2012 Sep 60 (10): 898-907.
Cresci Sharon, Dorn Gerald W, Jones Philip G, Beitelshees Amber L, Li Allie Y, Lenzini Petra A, Province Michael A, Spertus John A, Lanfear David
Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
JAMA 2005 Sep 294 (12): 1526-33.
Lanfear David E, Jones Philip G, Marsh Sharon, Cresci Sharon, McLeod Howard L, Spertus John